ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...

Non-Hallucinogenic Psychedelics or Short Term vs Long Term Acting Psychedelics, Which are Best.

Great Interview with Adam Tubero, Jake Slomowitz and Steve McCraken, Analyst's who Drink the Kool Aide for...

Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7. Pure Genius. Interview With Jonathan Sabbagh, CEO

Journey Clinical is on a mission to expand access to transformative, evidence-based psychedelic therapies, starting with Ketamine-Assisted Psychotherapy (KAP).

Guide to Miami Hedge Fund Week 2024

Each year, an intense series of alternative investment conferences take place in and around Miami. Here are the events for 2024...

Helping Ketamine Clinics Succeed. Beyond Marketing.

Beyond Marketing Helps Transform Mental Health, TMS & Ketamine Practices into Thriving Businesses. The way patients behave...

Lykos Therapeutics (formerly MAPS) Raises $100 Million. Cha-Ching.

MDMA therapy company Lykos raises $100M in Series A funding as it eyes FDA approval (MarketWatch). MAPS Public Benefit Corp. changes...

ATAI to Invest $50 Million in Beckley Psytech

-Strategic investment in Beckley Psytech reinforces atai’s position as the biopharmaceutical company with the largest and most diverse portfolio of...

Psychedelic Support Team! The Fireside Project.

Fireside Project was born at a unique moment in history. It was the spring of 2020. The pandemic was raging. Depression, anxiety,...

Blake Mycoskie Pledging $100 Million to Psychedelic Research (MarketWatch).

Donation is believed to be ‘biggest that we’ve ever seen in the psychedelics space.’ Quest for treatments for depression, PTSD centers...

Free Psychedelic Help is Just a Call or Text Away! Fireside Project.

Interview with Hanifa Nayo Washington and Joshua White of Fireside Project. September 24th, 2021. If you...

NRx Pharma (NRXP) Presentation at Sachs Neuroscience Forum.

Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, gives the keynote address "Ketamine for Suicidal Depression: The Benefits...

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS